Literature DB >> 25634715

Pixel-by-Pixel Comparison of Volume Transfer Constant and Estimates of Cerebral Blood Volume from Dynamic Contrast-Enhanced and Dynamic Susceptibility Contrast-Enhanced MR Imaging in High-Grade Gliomas.

P Alcaide-Leon1, D Pareto2, E Martinez-Saez3, C Auger2, A Bharatha4, A Rovira2.   

Abstract

BACKGROUND AND
PURPOSE: Estimates of blood volume and volume transfer constant are parameters commonly used to characterize hemodynamic properties of brain lesions. The purposes of this study were to compare values of volume transfer constant and estimates of blood volume in high-grade gliomas on a pixel-by-pixel basis to comprehend whether they provide different information and to compare estimates of blood volume obtained by dynamic contrast-enhanced MR imaging and dynamic susceptibility contrast-enhanced MR imaging.
MATERIALS AND METHODS: Thirty-two patients with biopsy-proved grade IV gliomas underwent dynamic contrast-enhanced MR imaging and dynamic susceptibility contrast-enhanced MR imaging, and parametric maps of volume transfer constant, plasma volume, and CBV maps were calculated. The Spearman rank correlation coefficients among matching values of CBV, volume transfer constant, and plasma volume were calculated on a pixel-by-pixel basis. Comparison of median values of normalized CBV and plasma volume was performed.
RESULTS: Weak-but-significant correlation (P < .001) was noted for all comparisons. Spearman rank correlation coefficients were as follows: volume transfer constant versus CBV, ρ = 0.113; volume transfer constant versus plasma volume, ρ = 0.256; CBV versus plasma volume, ρ = 0.382. We found a statistically significant difference (P < .001) for the estimates of blood volume obtained by using dynamic contrast-enhanced MR imaging (mean normalized plasma volume, 13.89 ± 11.25) and dynamic susceptibility contrast-enhanced MR imaging (mean normalized CBV, 4.37 ± 4.04).
CONCLUSIONS: The finding of a very weak correlation between estimates of microvascular density and volume transfer constant suggests that they provide different information. Estimates of blood volume obtained by using dynamic contrast-enhanced MR imaging are significantly higher than those obtained by dynamic susceptibility contrast-enhanced MR imaging in human gliomas, most likely due to the effect of contrast leakage.
© 2015 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25634715      PMCID: PMC7990585          DOI: 10.3174/ajnr.A4231

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  26 in total

1.  Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT [corrected].

Authors:  Yue Cao; Christina I Tsien; Vijaya Nagesh; Larry Junck; Randall Ten Haken; Brian D Ross; Thomas L Chenevert; Theodore S Lawrence
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-11-18       Impact factor: 7.038

2.  Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors.

Authors:  Eric S Paulson; Kathleen M Schmainda
Journal:  Radiology       Date:  2008-09-09       Impact factor: 11.105

3.  MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy.

Authors:  Shahrzad Jalali; Caroline Chung; Warren Foltz; Kelly Burrell; Sanjay Singh; Richard Hill; Gelareh Zadeh
Journal:  Neuro Oncol       Date:  2014-04-23       Impact factor: 12.300

4.  Is volume transfer coefficient (K(trans)) related to histologic grade in human gliomas?

Authors:  Tufail F Patankar; Hamied A Haroon; Samantha J Mills; Danielle Balériaux; David L Buckley; Geoff J M Parker; Alan Jackson
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

Review 5.  Perfusion MRI: the five most frequently asked technical questions.

Authors:  Marco Essig; Mark S Shiroishi; Thanh Binh Nguyen; Marc Saake; James M Provenzale; David Enterline; Nicoletta Anzalone; Arnd Dörfler; Alex Rovira; Max Wintermark; Meng Law
Journal:  AJR Am J Roentgenol       Date:  2013-01       Impact factor: 3.959

6.  Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography.

Authors:  Lutz Lüdemann; Carsten Warmuth; Michail Plotkin; Annette Förschler; Matthias Gutberlet; Peter Wust; Holger Amthauer
Journal:  Eur J Radiol       Date:  2008-03-24       Impact factor: 3.528

7.  Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.

Authors:  Meng Law; Stanley Yang; James S Babb; Edmond A Knopp; John G Golfinos; David Zagzag; Glyn Johnson
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

8.  A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients.

Authors:  A Gregory Sorensen; Tracy T Batchelor; Wei-Ting Zhang; Poe-Jou Chen; Priscilla Yeo; Meiyun Wang; Dominique Jennings; Patrick Y Wen; Johanna Lahdenranta; Marek Ancukiewicz; Emmanuelle di Tomaso; Dan G Duda; Rakesh K Jain
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

9.  Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting.

Authors:  R Bruening; K K Kwong; M J Vevea; F H Hochberg; L Cher; G R Harsh; P T Niemi; R M Weisskoff; B R Rosen
Journal:  AJNR Am J Neuroradiol       Date:  1996-05       Impact factor: 3.825

Review 10.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

View more
  10 in total

1.  "Comment on Hatzoglou et al.: Dynamic contrast-enhanced MRI perfusion vs 18FDG PET/CT in differentiating brain tumor progression from radiation injury"-Reply.

Authors:  Robert J Young; T Jonathan Yang; Vaios Hatzoglou; Gary Ulaner; Antonio Omuro
Journal:  Neuro Oncol       Date:  2017-02-01       Impact factor: 12.300

2.  A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation.

Authors:  Vaios Hatzoglou; T Jonathan Yang; Antonio Omuro; Igor Gavrilovic; Gary Ulaner; Jennifer Rubel; Taylor Schneider; Kaitlin M Woo; Zhigang Zhang; Kyung K Peck; Kathryn Beal; Robert J Young
Journal:  Neuro Oncol       Date:  2015-12-19       Impact factor: 12.300

3.  The Added Prognostic Value of Preoperative Dynamic Contrast-Enhanced MRI Histogram Analysis in Patients with Glioblastoma: Analysis of Overall and Progression-Free Survival.

Authors:  Y S Choi; D W Kim; S-K Lee; J H Chang; S-G Kang; E H Kim; S H Kim; T H Rim; S S Ahn
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-03       Impact factor: 3.825

4.  Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas.

Authors:  Julio Arevalo-Perez; Amanuel A Kebede; Kyung K Peck; Eli Diamond; Andrei I Holodny; Marc Rosenblum; Jennifer Rubel; Joshua Gaal; Vaios Hatzoglou
Journal:  J Neuroimaging       Date:  2015-12-26       Impact factor: 2.486

5.  Comparison of Cerebral Blood Volume and Plasma Volume in Untreated Intracranial Tumors.

Authors:  Soha Bazyar; Joana Ramalho; Cihat Eldeniz; Hongyu An; Yueh Z Lee
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

6.  Developing a Pipeline for Multiparametric MRI-Guided Radiation Therapy: Initial Results from a Phase II Clinical Trial in Newly Diagnosed Glioblastoma.

Authors:  Michelle M Kim; Hemant A Parmar; Madhava P Aryal; Charles S Mayo; James M Balter; Theodore S Lawrence; Yue Cao
Journal:  Tomography       Date:  2019-03

7.  Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study.

Authors:  Michele Bailo; Nicolò Pecco; Marcella Callea; Paola Scifo; Filippo Gagliardi; Luca Presotto; Valentino Bettinardi; Federico Fallanca; Paola Mapelli; Luigi Gianolli; Claudio Doglioni; Nicoletta Anzalone; Maria Picchio; Pietro Mortini; Andrea Falini; Antonella Castellano
Journal:  Front Neurosci       Date:  2022-07-13       Impact factor: 5.152

8.  Specific Preoperative Dynamic Contrast-Enhanced MRI Semi-quantitative Markers Can Correlate With Vascularity in Specific Areas of Glioblastoma Tissue and Predict Recurrence.

Authors:  Mohammed A Azab; Sherief Ghozy; Sherif F Hassanein; Ahmed Y Azzam
Journal:  Cureus       Date:  2021-06-08

9.  Histogram analysis of absolute cerebral blood volume map can distinguish glioblastoma from solitary brain metastasis.

Authors:  Jianhua Qin; Ying Li; Donghai Liang; Yuanna Zhang; Weicheng Yao
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

10.  Cerebral and tumoral blood flow in adult gliomas: a systematic review of results from magnetic resonance imaging.

Authors:  Mueez Waqar; Daniel Lewis; Erjon Agushi; Matthew Gittins; Alan Jackson; David Coope
Journal:  Br J Radiol       Date:  2021-06-09       Impact factor: 3.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.